Exploring Novel Aptamer-Heparin Combinations to Improve Anticoagulation Therapy in Cardiopulmonary Bypass

被引：0
|
作者：
Chabata, Charlene V. [1 ]
Gunaratne, Ruwan [1 ]
Frederiksen, James W. [1 ]
Sullenger, Bruce A. [1 ]
机构：
[1] Duke Univ, Pharmacol, Durham, NC USA
来源：
MOLECULAR THERAPY | 2019年 / 27卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
784
引用
收藏
页码：364 / 365
页数：2
相关论文
共 50 条
  • [21] Aptamer to factor IXa and its matched antidote in cardiopulmonary bypass: An alternative to heparin and protamine
    Nimjee, SM
    Keys, JR
    Pitoc, GA
    Quick, G
    Rusconi, CP
    Sullenger, BA
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (05) : E7 - E7
  • [22] Cardiopulmonary bypass for complex cardiac surgery using bivalirudin anticoagulation in a patient with heparin antibodies
    Huebler, M
    Koster, A
    Buz, S
    Boettcher, W
    Hetzer, R
    Kuppe, H
    Dyke, CM
    JOURNAL OF CARDIAC SURGERY, 2006, 21 (03) : 286 - 288
  • [23] Heparin induced thrombocytopenia and cardiopulmonary bypass strategy for cardiac surgery: which anticoagulation in 2009?
    Durand, Marion
    Devignes, Jean
    Hacquard, Marie
    Perrin, Julien
    Hirschi, Marie
    Carteaux, Jean-Pierre
    Lecompte, Thomas
    SANG THROMBOSE VAISSEAUX, 2009, 21 (02): : 71 - 77
  • [24] A novel Thrombelastograph® tissue factor/kaolin assay of activated clotting times for monitoring heparin anticoagulation during cardiopulmonary bypass
    Chavez, JJ
    Foley, DE
    Snider, CC
    Howell, JC
    Cohen, E
    Muenchen, RA
    Carroll, RC
    ANESTHESIA AND ANALGESIA, 2004, 99 (05): : 1290 - 1294
  • [25] The Use of Bivalirudin for Cardiopulmonary Bypass Anticoagulation in Pediatric Heparin-Induced Thrombocytopenia Patients
    Gates, Richard
    Yost, Paul
    Parker, Beth
    ARTIFICIAL ORGANS, 2010, 34 (08) : 667 - U2
  • [26] Alternatives to unfractioned heparin for anticoagulation in cardiopulmonary bypass (vol 16, pg 411, 2001)
    von Segesser, LK
    PERFUSION-UK, 2002, 17 (02): : 158 - 158
  • [27] HEPARIN-FREE CARDIOPULMONARY BYPASS - 1ST REPORTED USE OF HEPARINOID (ORG 10172) TO PROVIDE ANTICOAGULATION FOR CARDIOPULMONARY BYPASS
    DOHERTY, DC
    ORTEL, TL
    DEBRUIJN, N
    GREENBERG, CS
    VANTRIGT, P
    ANESTHESIOLOGY, 1990, 73 (03) : 562 - 565
  • [28] Heparin-induced antibody formation in patients undergoing cardiopulmonary bypass surgery with bovine or porcine heparin anticoagulation
    Konkle, BA
    Bauer, TL
    Mestichelli, B
    Palermo, C
    Cines, DB
    Poncz, M
    McNulty, S
    Edie, RN
    Mannion, JD
    THROMBOSIS AND HAEMOSTASIS, 1999, : 60 - 60
  • [29] Assessing the impact of different heparin dosing regimens for cardiopulmonary bypass on anticoagulation: the HepDOSE pilot study
    Lwin, Thar Nyan
    Mudannayake, Rahul
    MacDonald, Stephen
    Arrowsmith, Joseph E.
    Burt, Christiana
    Besser, Martin
    Falter, Florian
    CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 2024, 71 (02): : 234 - 243
  • [30] HEPARIN MANAGEMENT TEST - AN IMPROVED METHOD OF ASSESSING ANTICOAGULATION DURING CARDIOPULMONARY BYPASS IN THE PEDIATRIC POPULATION
    OWINGS, JT
    POLLOCK, ME
    GOSSELIN, RC
    IRELAND, K
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 976 - 976
12345